Monitoring C2 Level Predicts Exposure in Maintenance Lung Transplant Patients Receiving the Microemulsion Formulation of Cyclosporine (Neoral)

C2 is the single time-point that correlates most closely with AUC0-4 in lung transplant recipients without gastroparesis. It remains to be demonstrated whether monitoring CsA based on C2 levels results in a lower incidence of rejection without additional toxicity.